Recent Advances on the Molecular Mechanism and Clinical Trials of Venous Thromboembolism

References

• Alirezaei T, Sattari H, Irilouzadian R. Significant decrease in plasma D-dimer levels and mean platelet volume after a 3-month treatment with rosuvastatin in patients with venous thromboembolism. Clin Cardiol. 2022;45(7):717–722. doi:10.1002/clc.23833
   PubMed Web of Science ®Google Scholar
• Lutsey PL, Zakai NA. Epidemiology and prevention of venous thromboembolism. Nat Rev Cardiol. 2023;20(4):248–262. doi:10.1038/s41569-022-00787-6
   PubMed Web of Science ®Google Scholar
• Zoller B, Svensson PJ, Dahlback B, Lind-Hallden C, Hallden C, Elf J. Genetic risk factors for venous thromboembolism. Expert Rev Hematol. 2020;13(9):971–981. doi:10.1080/17474086.2020.1804354
   PubMed Web of Science ®Google Scholar
• Næss IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population‐based study. J Thromb Haemost. 2007;5(4):692–699. doi:10.1111/j.1538-7836.2007.02450.x
   PubMed Web of Science ®Google Scholar
• Liang J, Mei S, Qiao X, et al. A botanical medicine dragon’s blood exhibited clinical antithrombosis efficacy similar to low molecular weight heparin. Sci China Life Sci. 2021;64(10):1691–1701. doi:10.1007/s11427-020-1848-8
   PubMed Web of Science ®Google Scholar
• Koitabashi N, Niwamae N, Taguchi T, Ohyama Y, Takama N, Kurabayashi M. Remarkable regression of massive deep vein thrombosis in response to intensive oral rivaroxaban treatment. Thromb J. 2015;13(1):13. doi:10.1186/s12959-015-0045-1
   PubMedGoogle Scholar
• Momi S, Canino J, Vismara M, et al. Proline-rich tyrosine kinase Pyk2 regulates deep vein thrombosis. Haematologica. 2022;107(6):1374–1383. doi:10.3324/haematol.2021.279703
   PubMed Web of Science ®Google Scholar
• Tang JJ, Meng QY, Cai ZX, Li XQ. Corrigendum to “Transplantation of VEGFl65-overexpressing vascular endothelial progenitor cells relieves endothelial injury after deep vein thrombectomy” [Thromb. Res. 137 (2016) 41–45]. Thromb Res. 2017;154:107. doi:10.1016/j.thromres.2017.04.026
   PubMed Web of Science ®Google Scholar
• Jin T, Jiang L, Zhang X. Influence of Lower Extremity Deep Venous Thrombosis in Cerebral Infarction on Coagulation Index and Thromboelastogram and Its Risk Factors. J Healthc Eng. 2022;2022:1–6.
   Web of Science ®Google Scholar
• Han Y, Bai X, Wang X. Exosomal myeloperoxidase as a biomarker of deep venous thrombosis. Ann Transl Med. 2022;10(1):9. doi:10.21037/atm-21-5583
   PubMed Web of Science ®Google Scholar
• Akpinar EE, Hosgun D, Akan B, Ates C, Gulhan M. Does thromboprophylaxis prevent venous thromboembolism after major orthopedic surgery? J Bras Pneumol. 2013;39(3):280–286. doi:10.1590/S1806-37132013000300004
   PubMed Web of Science ®Google Scholar
• Torres-Macho J, Mancebo-Plaza AB, Crespo-Gimenez A, et al. Clinical features of patients inappropriately undiagnosed of pulmonary embolism. Am J Emerg Med. 2013;31(12):1646–1650. doi:10.1016/j.ajem.2013.08.037
   PubMed Web of Science ®Google Scholar
• Elliott CG, Goldhaber SZ, Jensen RL. Delays in diagnosis of deep vein thrombosis and pulmonary embolism. Chest. 2005;128(5):3372–3376. doi:10.1378/chest.128.5.3372
   PubMed Web of Science ®Google Scholar
• Declerck PJ, Gils A. Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin. Semin Thromb Hemost. 2013;39(04):356–364. doi:10.1055/s-0033-1334487
   PubMedGoogle Scholar
• Nougier C, Benoit R, Simon M, et al. Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosis. J Thromb Haemost. 2020;18(9):2215–2219. doi:10.1111/jth.15016
   PubMed Web of Science ®Google Scholar
• Meltzer ME, Lisman T, de Groot PG, et al. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood. 2010;116(1):113–121. doi:10.1182/blood-2010-02-267740
   PubMed Web of Science ®Google Scholar
• Erkal B, Kalayci Yigin A, Palanduz S, Dasdemir S, Seven M. The Effect of PAI-1 Gene Variants and PAI-1 Plasma Levels on Development of Thrombophilia in Patients With Klinefelter Syndrome. Am J Men’s Health. 2018;12(6):2152–2156. doi:10.1177/1557988318801158
   PubMed Web of Science ®Google Scholar
• Vuckovic BA, Djeric MJ, Tomic BV, Djordjevic VJ, Bajkin BV, Mitic GP. Influence of decreased fibrinolytic activity and plasminogen activator inhibitor-1 4G/5G polymorphism on the risk of venous thrombosis. Blood Coagul Fibrin. 2018;29(1):19–24. doi:10.1097/MBC.0000000000000656
   PubMed Web of Science ®Google Scholar
• Sundquist K, Wang X, Svensson PJ, et al. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence. Thromb Haemostasis. 2015;114(12):1156–1164. doi:10.1160/TH15-01-0031
   PubMedGoogle Scholar
• Li H, Zhang B, Lu S, et al. siRNA-mediated silencing of PAI-1 gene acts as a promoter over the recanalization of endothelial progenitor cells in rats with venous thrombosis. J Cell Physiol. 2019;234(11):19921–19932. doi:10.1002/jcp.28590
   PubMed Web of Science ®Google Scholar
• Shi K, Tian DC, Li ZG, Ducruet AF, Lawton MT, Shi FD. Global brain inflammation in stroke. Lancet Neurol. 2019;18(11):1058–1066. doi:10.1016/S1474-4422(19)30078-X
   PubMed Web of Science ®Google Scholar
• Atkinson AJ, Colburn WA, DeGruttola VG, et al; Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89–95. doi:10.1067/mcp.2001.113989
   PubMed Web of Science ®Google Scholar
• Hickey BA, Cleves A, Alikhan R, Pugh N, Nokes L, Perera A. Can we use biomarkers of coagulation to predict which patients with foot and ankle injury will develop deep vein thrombosis? Foot Ankle Surg. 2019;25(1):59–62. doi:10.1016/j.fas.2017.08.002
   PubMed Web of Science ®Google Scholar
• Obi AT, Sharma SB, Elfline MA, et al. Experimental venous thrombus resolution is driven by IL-6 mediated monocyte actions. Sci Rep. 2023;13(1):3253.
   PubMed Web of Science ®Google Scholar
• Shahneh F, Christian Probst H, Wiesmann SC, et al. Inflammatory monocyte counts determine venous blood clot formation and resolution. Arterioscler Thromb Vasc Biol. 2022;42(2):145–155. doi:10.1161/ATVBAHA.121.317176
   PubMed Web of Science ®Google Scholar
• Pai RZ, Fang Q, Tian G, Zhu B, Ge X. Expression and role of interleukin-1beta and associated biomarkers in deep vein thrombosis. Exp Ther Med. 2021;22(6):1366. doi:10.3892/etm.2021.10800
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S, Johnson TA, Duru N, et al. Fibrinolysis and inflammation in venous thrombus resolution. Front Immunol. 2019;10:1348. doi:10.3389/fimmu.2019.01348
   PubMed Web of Science ®Google Scholar
• Deguchi H, Elias DJ, Navarro S, Espana F, Griffin JH. Elevated serum amyloid A is associated with venous thromboembolism. Thromb Haemostasis. 2013;109(02):358–359. doi:10.1160/TH12-10-0722
   PubMedGoogle Scholar
• Abuduhalike R, Abudouwayiti A, Juan S, MaheMuti A. Study on the Mechanism of NLRP3/IL-1/ NF-κB signaling pathway and macrophage polarization in the occurrence and development of VTE. Ann Vasc Surg. 2023;89:280–292. doi:10.1016/j.avsg.2022.09.056
   PubMed Web of Science ®Google Scholar
• Meng Y, Yin Q, Ma Q, et al. FXII regulates the formation of deep vein thrombosis via the PI3K/AKT signaling pathway in mice. Int J Mol Med. 2021;47(5):1–3.
   PubMed Web of Science ®Google Scholar
• Xie W, Zhang L, Luo W, Zhai Z, Wang C, Shen YH. AKT2 regulates endothelial-mediated coagulation homeostasis and promotes intrathrombotic recanalization and thrombus resolution in a mouse model of venous thrombosis. J Thromb Thrombolys. 2020;50(1):98–111. doi:10.1007/s11239-020-02112-9
   PubMed Web of Science ®Google Scholar
• Cheng X, Sun B, Liu S, Li D, Yang X, Zhang Y. Identification of thrombomodulin as a dynamic monitoring biomarker for deep venous thrombosis evolution. Exp Ther Med. 2021;21(2):142. doi:10.3892/etm.2020.9574
   PubMed Web of Science ®Google Scholar
• Schmaier AA, Anderson PF, Chen SM, et al. TMEM16E regulates endothelial cell procoagulant activity and thrombosis. J Clin Invest. 2023;133(11). doi:10.1172/JCI163808
   PubMed Web of Science ®Google Scholar
• Filep JG. Two to tango: endothelial cell TMEM16 scramblases drive coagulation and thrombosis. J Clin Invest. 2023;133(11). doi:10.1172/JCI170643
   PubMed Web of Science ®Google Scholar
• Kondreddy V, Magisetty J, Keshava S, Rao LVM, Pendurthi UR. Gab2 (Grb2-Associated Binder2) plays a crucial role in inflammatory signaling and endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2021;41(6):1987–2005. doi:10.1161/ATVBAHA.121.316153
   PubMed Web of Science ®Google Scholar
• Kondreddy V, Keshava S, Das K, Magisetty J, Rao L, Pendurthi UR. The Gab2-MALT1 axis regulates thromboinflammation and deep vein thrombosis. Blood. 2022;140(13):1549–1564. doi:10.1182/blood.2022016424
   PubMed Web of Science ®Google Scholar
• Dias L, Pinto MJ, Castro P, Carvalho M. Inflammatory biomarkers correlate with time evolution in cerebral venous thrombosis. J Stroke Cerebrovascular Dis. 2021;30(7):105844. doi:10.1016/j.jstrokecerebrovasdis.2021.105844
   PubMed Web of Science ®Google Scholar
• Abe H, Kunita A, Otake Y, et al. Virus-host interactions in carcinogenesis of Epstein-Barr virus-associated gastric carcinoma: potential roles of lost ARID1A expression in its early stage. PLoS One. 2021;16(9):e256440. doi:10.1371/journal.pone.0256440
   Web of Science ®Google Scholar
• Beurel E, Grieco SF, Jope RS. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Therapeut. 2015;148:114–131.
   PubMed Web of Science ®Google Scholar
• Kaidanovich-Beilin O, Woodgett JR. GSK-3: functional insights from cell biology and animal models. Front Mol Neurosci. 2011;4. doi:10.3389/fnmol.2011.00040
   PubMed Web of Science ®Google Scholar
• Lu R, Zhu W, Sun H, et al. Study on the effect and mechanism of miR-185 on lower extremity deep venous thrombosis. Mol Biotechnol. 2022;64(3):330–337. doi:10.1007/s12033-021-00412-w
   PubMed Web of Science ®Google Scholar
• Wang W, Zhu X, Du X, et al. MiR-150 promotes angiogensis and proliferation of endothelial progenitor cells in deep venous thrombosis by targeting SRCIN1. Microvasc Res. 2019;123:35–41. doi:10.1016/j.mvr.2018.10.003
   PubMed Web of Science ®Google Scholar
• Du X, Hong L, Sun L, et al. miR-21 induces endothelial progenitor cells proliferation and angiogenesis via targeting FASLG and is a potential prognostic marker in deep venous thrombosis. J Transl Med. 2019;17(1). doi:10.1186/s12967-019-2015-z
   Web of Science ®Google Scholar
• Laurent P, Severin S, Gratacap M, Payrastre B. Class I PI 3-kinases signaling in platelet activation and thrombosis: PDK1/Akt/GSK3 axis and impact of PTEN and SHIP1. Adv Bio Regul 2014;54:162–174. doi:10.1016/j.jbior.2013.09.006
   PubMedGoogle Scholar
• Xie J, Wu W, Zheng L, et al. Roles of MicroRNA-21 in skin wound healing: a comprehensive review. Front Pharmacol. 2022;13:828627. doi:10.3389/fphar.2022.828627
   PubMed Web of Science ®Google Scholar
• Surina S, Fontanella RA, Scisciola L, Marfella R, Paolisso G, Barbieri M. miR-21 in Human Cardiomyopathies. Front Cardiovasc Med. 2021;8:767064. doi:10.3389/fcvm.2021.767064
   PubMed Web of Science ®Google Scholar
• Rosendaal FR. Thrombosis in the young: epidemiology and risk factors. a focus on venous thrombosis. Thromb Haemostasis. 2018;78:1–6.
   Google Scholar
• Lou Z, Zhu J, Li X, et al. LncRNA Sirt1-AS upregulates Sirt1 to attenuate aging related deep venous thrombosis. Aging. 2021;13(5):6918–6935. doi:10.18632/aging.202550
   PubMedGoogle Scholar
• Kumar R, Sonkar VK, Swamy J, et al. DNase 1 protects from increased thrombin generation and venous thrombosis during aging: cross‐sectional study in mice and humans. J Am Heart Assoc. 2022;11(2). doi:10.1161/JAHA.121.021188
   Web of Science ®Google Scholar
• Fuchs TA, Abed U, Goosmann C, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 2007;176(2):231–241. doi:10.1083/jcb.200606027
   PubMed Web of Science ®Google Scholar
• Constantinescu-Bercu A, Grassi L, Frontini M, Salles-Crawley II, Woollard K, Crawley JT. Activated αIIbβ3 on platelets mediates flow-dependent NETosis via SLC44A2. Elife. 2020;9. doi:10.7554/eLife.53353
   PubMed Web of Science ®Google Scholar
• von Bruhl ML, Stark K, Steinhart A, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med. 2012;209(4):819–835. doi:10.1084/jem.20112322
   PubMed Web of Science ®Google Scholar
• Sharma S, Hofbauer TM, Ondracek AS, et al. Neutrophil extracellular traps promote fibrous vascular occlusions in chronic thrombosis. Blood. 2021;137(8):1104–1116. doi:10.1182/blood.2020005861
   PubMed Web of Science ®Google Scholar
• Secomb TW. Hemodynamics. Compr Physiol. 2016;6:975–1003.
   PubMed Web of Science ®Google Scholar
• Aird WC. Phenotypic heterogeneity of the endothelium: i. Structure, function, and mechanisms. Circ Res. 2007;100(2):158–173. doi:10.1161/01.RES.0000255691.76142.4a
   PubMed Web of Science ®Google Scholar
• Nayak L, Sweet DR, Thomas A, et al. A targetable pathway in neutrophils mitigates both arterial and venous thrombosis. Sci Transl Med. 2022;14(660):j7465. doi:10.1126/scitranslmed.abj7465
   Web of Science ®Google Scholar
• Tang X, Wang P, Zhang R, et al. KLF2 regulates neutrophil activation and thrombosis in cardiac hypertrophy and heart failure progression. J Clin Invest. 2022;132(3). doi:10.1172/JCI147191
   Web of Science ®Google Scholar
• Petzold T, Zhang Z, Ballesteros I, et al. Neutrophil “plucking” on megakaryocytes drives platelet production and boosts cardiovascular disease. Immunity. 2022;55(12):2285–2299. doi:10.1016/j.immuni.2022.10.001
   PubMed Web of Science ®Google Scholar
• Dhanesha N, Jain M, Doddapattar P, Undas A, Chauhan AK. Cellular fibronectin promotes deep vein thrombosis in diet‐induced obese mice. J Thromb Haemost. 2021;19(3):814–821. doi:10.1111/jth.15206
   PubMed Web of Science ®Google Scholar
• Dhanesha N, Ahmad A, Prakash P, Doddapattar P, Lentz SR, Chauhan AK. Genetic ablation of extra domain A of fibronectin in hypercholesterolemic mice improves stroke outcome by reducing thrombo-inflammation. Circulation. 2015;132(23):2237–2247. doi:10.1161/CIRCULATIONAHA.115.016540
   PubMed Web of Science ®Google Scholar
• Dhanesha N, Chorawala MR, Jain M, et al. Fn-EDA (Fibronectin Containing Extra Domain A) in the plasma, but not endothelial cells, exacerbates stroke outcome by promoting thrombo-inflammation. Stroke. 2019;50(5):1201–1209. doi:10.1161/STROKEAHA.118.023697
   PubMed Web of Science ®Google Scholar
• Chorawala MR, Prakash P, Doddapattar P, Jain M, Dhanesha N, Chauhan AK. Deletion of extra Domain A of fibronectin reduces acute myocardial ischaemia/reperfusion injury in hyperlipidaemic mice by limiting thrombo-inflammation. Thromb Haemostasis. 2018;118(08):1450–1460. doi:10.1055/s-0038-1661353
   PubMedGoogle Scholar
• Doddapattar P, Jain M, Dhanesha N, Lentz SR, Chauhan AK. Fibronectin containing extra domain A induces plaque destabilization in the innominate artery of aged apolipoprotein E-deficient mice. Arterioscl Throm Vas. 2018;38(3):500–508. doi:10.1161/ATVBAHA.117.310345
   Google Scholar
• Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med. 2005;118(9):978–980. doi:10.1016/j.amjmed.2005.03.012
   PubMed Web of Science ®Google Scholar
• Klovaite J, Benn M, Nordestgaard BG. Obesity as a causal risk factor for deep venous thrombosis: a M endelian randomization study. J Intern Med. 2015;277(5):573–584. doi:10.1111/joim.12299
   PubMed Web of Science ®Google Scholar
• Ali RA, Estes SK, Gandhi AA, et al. Defibrotide inhibits antiphospholipid antibody-mediated neutrophil extracellular trap formation and venous thrombosis. Arthritis Rheumatol. 2022;74(5):902–907. doi:10.1002/art.42017
   PubMed Web of Science ®Google Scholar
• Neri T, Nieri D, Celi A. P-selectin blockade in COVID-19-related ARDS. Am J Physiol Lung C. 2020;318(6):L1237–L1238. doi:10.1152/ajplung.00202.2020
   PubMed Web of Science ®Google Scholar
• Feng Q, Wang M, Muhtar E, Wang Y, Zhu H. Nanoparticles of a new small-molecule P-selectin inhibitor attenuate thrombosis, inflammation, and tumor growth in two animal models. Int J Nanomed. 2021;16:5777–5795. doi:10.2147/IJN.S316863
   PubMed Web of Science ®Google Scholar
• Japp AG, Chelliah R, Tattersall L, et al. Effect of PSI‐697, a novel P‐selectin inhibitor, on platelet–monocyte aggregate formation in humans. J Am Heart Assoc. 2013;2(1):e6007. doi:10.1161/JAHA.112.006007
   Web of Science ®Google Scholar
• Reitsma PH, Versteeg HH, Middeldorp S. Mechanistic view of risk factors for venous thromboembolism. Arterioscl Throm Vas. 2012;32(3):563–568. doi:10.1161/ATVBAHA.111.242818
   Google Scholar
• Bovill EG, van der Vliet A. Venous valvular stasis-associated hypoxia and thrombosis: what is the link? Annu Rev Physiol. 2011;73(1):527–545. doi:10.1146/annurev-physiol-012110-142305
   PubMedGoogle Scholar
• Collard CD, Montalto MC, Reenstra WR, Buras JA, Stahl GL. Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1. Am J Pathol. 2001;159(3):1045–1054. doi:10.1016/S0002-9440(10)61779-8
   PubMed Web of Science ®Google Scholar
• Kataoka H, Hamilton JR, McKemy DD, et al. Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood. 2003;102(9):3224–3231. doi:10.1182/blood-2003-04-1130
   PubMed Web of Science ®Google Scholar
• Durigutto P, Macor P, Pozzi N, et al. Complement activation and thrombin generation by MBL bound to beta2-Glycoprotein I. J Immunol. 2020;205(5):1385–1392. doi:10.4049/jimmunol.2000570
   PubMed Web of Science ®Google Scholar
• Damoah CE, Snir O, Hindberg K, et al. High levels of complement activating enzyme MASP-2 are associated with the risk of future incident venous thromboembolism. Arterioscler Thromb Vasc Biol. 2022;42(9):1186–1197. doi:10.1161/ATVBAHA.122.317746
   PubMed Web of Science ®Google Scholar
• Hasselwander S, Xia N, Mimmler M, et al. B lymphocyte-deficiency in mice promotes venous thrombosis. Heliyon. 2022;8(11):e11740. doi:10.1016/j.heliyon.2022.e11740
   PubMed Web of Science ®Google Scholar
• Bertin FR, Rys RN, Mathieu C, Laurance S, Lemarié CA, Blostein MD. Natural killer cells induce neutrophil extracellular trap formation in venous thrombosis. J Thromb Haemost. 2019;17(2):403–414. doi:10.1111/jth.14339
   PubMed Web of Science ®Google Scholar
• Luther N, Shahneh F, Brahler M, et al. Innate effector-memory T-cell activation regulates post-thrombotic vein wall inflammation and thrombus resolution. Circ Res. 2016;119(12):1286–1295. doi:10.1161/CIRCRESAHA.116.309301
   PubMed Web of Science ®Google Scholar
• Shahneh F, Grill A, Klein M, et al. Specialized regulatory T cells control venous blood clot resolution through SPARC. Blood. 2021;137(11):1517–1526. doi:10.1182/blood.2020005407
   PubMed Web of Science ®Google Scholar
• Lapointe C, Vincent L, Giguère H, et al. Chymase Inhibition resolves and prevents deep vein thrombosis without increasing bleeding time in the mouse model. J Am Heart Assoc. 2023;12(4). doi:10.1161/JAHA.122.028056
   PubMed Web of Science ®Google Scholar
• Thienel M, Muller-Reif JB, Zhang Z, et al. Immobility-associated thromboprotection is conserved across mammalian species from bear to human. Science. 2023;380(6641):178–187. doi:10.1126/science.abo5044
   PubMed Web of Science ®Google Scholar
• Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013;13(1):34–45. doi:10.1038/nri3345
   PubMed Web of Science ®Google Scholar
• Vazquez-Garza E, Jerjes-Sanchez C, Navarrete A, Joya-Harrison J, Rodriguez D. Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians. J Thromb Thrombolys. 2017;44(3):377–385. doi:10.1007/s11239-017-1528-7
   PubMed Web of Science ®Google Scholar
• Mankame AR, Sanders KE, Cardenas JC. Time-dependent changes in proinflammatory mediators are associated with trauma-related venous thromboembolism. Shock. 2023;60(5):637–645. doi:10.1097/SHK.0000000000002216
   PubMed Web of Science ®Google Scholar
• Geddings JE, Hisada Y, Boulaftali Y, et al. Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice. J Thromb Haemost. 2016;14(1):153–166. doi:10.1111/jth.13181
   PubMed Web of Science ®Google Scholar
• Ghosh A, Li W, Febbraio M, et al. Platelet CD36 mediates interactions with endothelial cell–derived microparticles and contributes to thrombosis in mice. J Clin Invest. 2008;118(5):1934–1943.
   PubMed Web of Science ®Google Scholar
• Falati S, Liu Q, Gross P, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med. 2003;197(11):1585–1598. doi:10.1084/jem.20021868
   PubMed Web of Science ®Google Scholar
• Rossaint J, Kuhne K, Skupski J, et al. Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response. Nat Commun. 2016;7(1):13464. doi:10.1038/ncomms13464
   PubMedGoogle Scholar
• Lin H, Chen H, Qi B, et al. Brain-derived extracellular vesicles mediated coagulopathy, inflammation and apoptosis after sepsis. Thromb Res. 2021;207:85–95. doi:10.1016/j.thromres.2021.09.014
   PubMed Web of Science ®Google Scholar
• Edelmann B, Gupta N, Schnoeder TM, et al. JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation. J Clin Invest. 2018;128(10):4359–4371. doi:10.1172/JCI90312
   PubMed Web of Science ®Google Scholar